InvestorsHub Logo
Followers 0
Posts 421
Boards Moderated 0
Alias Born 10/12/2016

Re: Screech691 post# 17549

Wednesday, 09/27/2017 2:48:28 PM

Wednesday, September 27, 2017 2:48:28 PM

Post# of 34587
Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") announces it will be attending and delivering a presentation at the upcoming Canadian Securities Exchange sponsored "Cannabis in the Capital Markets" event on September 27, in Kelowna, British Columbia. Also presenting at the event will be Dr. Philip Ainsle, Co-Director of the Centre for Heart, Lung and Vascular Health, UBC Okanagan Campus, Kelowna, Canada, who will be Principal Investigator of the previously announce clinical study to be conducted by UBC and Lexaria.

Chris must be making some impressions today.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LEXX News